ATE372340T1 - Zwischenprodukte für die herstellung von imidazo- pyridin-derivate - Google Patents

Zwischenprodukte für die herstellung von imidazo- pyridin-derivate

Info

Publication number
ATE372340T1
ATE372340T1 AT04023091T AT04023091T ATE372340T1 AT E372340 T1 ATE372340 T1 AT E372340T1 AT 04023091 T AT04023091 T AT 04023091T AT 04023091 T AT04023091 T AT 04023091T AT E372340 T1 ATE372340 T1 AT E372340T1
Authority
AT
Austria
Prior art keywords
production
intermediate products
imidazopyridine derivatives
imidazopyridine
derivatives
Prior art date
Application number
AT04023091T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE372340T1 publication Critical patent/ATE372340T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04023091T 1998-04-29 1999-04-23 Zwischenprodukte für die herstellung von imidazo- pyridin-derivate ATE372340T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds

Publications (1)

Publication Number Publication Date
ATE372340T1 true ATE372340T1 (de) 2007-09-15

Family

ID=20411154

Family Applications (4)

Application Number Title Priority Date Filing Date
AT04023090T ATE372339T1 (de) 1998-04-29 1999-04-23 Zwischenprodukte für die herstellung von imidazo- pyridin-derivate
AT99947037T ATE307130T1 (de) 1998-04-29 1999-04-23 Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.
AT04023091T ATE372340T1 (de) 1998-04-29 1999-04-23 Zwischenprodukte für die herstellung von imidazo- pyridin-derivate
AT99947038T ATE312101T1 (de) 1998-04-29 1999-04-23 Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT04023090T ATE372339T1 (de) 1998-04-29 1999-04-23 Zwischenprodukte für die herstellung von imidazo- pyridin-derivate
AT99947037T ATE307130T1 (de) 1998-04-29 1999-04-23 Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99947038T ATE312101T1 (de) 1998-04-29 1999-04-23 Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen

Country Status (33)

Country Link
US (2) US6313137B1 (de)
EP (4) EP1073657B1 (de)
JP (2) JP3883383B2 (de)
KR (3) KR100595805B1 (de)
CN (2) CN1165535C (de)
AR (2) AR015768A1 (de)
AT (4) ATE372339T1 (de)
AU (2) AU769108B2 (de)
BR (2) BR9909995B1 (de)
CA (2) CA2329921A1 (de)
CZ (2) CZ292567B6 (de)
DE (4) DE69937077T2 (de)
DK (2) DK1073656T3 (de)
EE (2) EE04676B1 (de)
ES (2) ES2252975T3 (de)
HU (2) HUP0102313A3 (de)
ID (2) ID27530A (de)
IL (4) IL139297A0 (de)
IS (2) IS5684A (de)
MY (2) MY121389A (de)
NO (2) NO317262B1 (de)
NZ (2) NZ507638A (de)
PL (2) PL343797A1 (de)
RU (2) RU2235725C2 (de)
SA (2) SA99200064B1 (de)
SE (1) SE9801526D0 (de)
SI (1) SI1073656T1 (de)
SK (2) SK285768B6 (de)
TR (4) TR200102728T2 (de)
TW (2) TW490466B (de)
UA (2) UA67769C2 (de)
WO (2) WO1999055706A1 (de)
ZA (2) ZA200005797B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
EP1368006B1 (de) * 2001-02-13 2006-05-03 AstraZeneca AB Neue formulierung mit modifizierter freisetzung
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
WO2004026867A2 (en) 2002-09-19 2004-04-01 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
HRP20050528A2 (en) 2002-11-19 2006-06-30 Altana Pharma Ag 8-substituted imidazopyridines
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1682133A1 (de) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo-1,2-a-pyridin-derivate zur behandlung von beschwerdefreiem gastroösophagealem reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
US20080033006A1 (en) * 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EA011512B1 (ru) * 2004-12-17 2009-04-28 Ракуалиа Фарма Инк. Производные хромана, полезные в качестве антагонистов кислотной помпы
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
AR056187A1 (es) * 2005-03-21 2007-09-26 S Bio Pte Ltd Derivados de imidazo[1,2-a)piridina: preparacion, composiciones farmaceuticas y uso para preparar medicamentos
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ(1,2−a)ピリジン誘導体
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
PT1963302E (pt) 2005-12-05 2013-04-09 Pfizer Prod Inc Polimorfos de um inibidor de c-met/hgfr
WO2007107827A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
US8728527B2 (en) 2006-07-24 2014-05-20 Luminus Biosciences, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
GB2471619B (en) * 2008-03-31 2012-10-31 Council Scient Ind Res Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2'-chloro-5-androsteno[17,6-B]pyridine
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
RU2403904C1 (ru) * 2009-02-26 2010-11-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Росздрава" Способ профилактики острых гастродуоденальных язв у больных колоректальным раком в раннем послеоперационном периоде
EP2452680B1 (de) * 2009-07-09 2019-12-18 RaQualia Pharma Inc. Säurepumpenantagonist zur behandlung von mit unnormalen magen-darm-bewegungen assoziierten erkrankungen
CA2913785C (en) * 2013-06-25 2021-08-31 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
AU2014365823B2 (en) 2013-12-16 2019-05-02 Abs Development 1, Inc. P2X3 and/or P2X2/3 compounds and methods
DK3122748T3 (en) * 2014-03-24 2018-11-05 Arqule Inc METHOD OF PREPARING 3- (3- (4- (1-AMINOCYCLOBUTYL) PHENYL) -5-PHENYL-3H-IMIDAZO [4,5-B] PYRIDIN-2-YL) PYRIDIN-2-AMINE
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂
ES3042162T3 (en) 2018-04-10 2025-11-18 Bayer Ag Method for the preparation of 2.6-dialkylphenyl acetic acids
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
EP4054537B1 (de) 2019-11-04 2023-06-07 Cinclus Pharma Holding AB (publ) Orale formulierung von x842
EP4426693A1 (de) 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphe des mesylatsalzes von linaprazanglurat
IL312564A (en) 2021-11-05 2024-07-01 Cinclus Pharma Holding Ab Publ Polymorphs of the hydrochloride salt of linfarezan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
JP2026503096A (ja) 2023-01-11 2026-01-27 シンクルス・ファーマ・ホールディング・アクチエボラグ・パブリーク リナプラザングルレート(linaprazan glurate)のマレイン酸塩の多形
WO2024149834A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrobromide salt of linaprazan glurate
MA72318A1 (fr) * 2023-02-01 2026-06-30 Jeil Pharmaceutical Co., Ltd. Formulation pharmaceutique, procédé de préparation s'y rapportant et composition de comprimé
WO2025215593A1 (en) * 2024-04-12 2025-10-16 Hetero Labs Limited An improved process for preparation of zastaprazan
TW202617716A (zh) * 2024-06-28 2026-05-01 南韓商第一藥品股份有限公司 咪唑并[1,2-a]吡啶化合物的新穎鹽及其製備方法
WO2026005543A1 (ko) * 2024-06-28 2026-01-02 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염의 결정형 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (de) * 1981-06-26 1986-03-05 Schering Corporation Imidazo(1,2-a)pyridine und -pyrazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (de) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridinverbindungen und Verfahren zu ihrer Herstellung
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
SK285768B6 (sk) 2007-07-06
MY121389A (en) 2006-01-28
ZA200005796B (en) 2002-01-18
RU2238271C2 (ru) 2004-10-20
DE69927803T2 (de) 2006-07-06
TR200003149T2 (tr) 2001-03-21
ATE372339T1 (de) 2007-09-15
NO20005450D0 (no) 2000-10-27
HUP0102425A3 (en) 2002-12-28
CN1307577A (zh) 2001-08-08
IL139297A0 (en) 2001-11-25
TWI250159B (en) 2006-03-01
RU2235725C2 (ru) 2004-09-10
IS5684A (is) 2000-10-25
EP1491543A1 (de) 2004-12-29
HUP0102425A2 (hu) 2001-11-28
CZ292567B6 (cs) 2003-10-15
AU4300699A (en) 1999-11-16
US6313136B1 (en) 2001-11-06
SA99200065B1 (ar) 2006-11-07
HK1033317A1 (en) 2001-08-24
AU769190B2 (en) 2004-01-22
EE200000664A (et) 2002-04-15
EP1491542B1 (de) 2007-09-05
NO20005451L (no) 2000-12-27
SA99200065A (ar) 2005-12-03
KR20010043133A (ko) 2001-05-25
HK1036981A1 (en) 2002-01-25
NO20005451D0 (no) 2000-10-27
BR9909995B1 (pt) 2010-07-13
NO20005450L (no) 2000-12-22
IL139297A (en) 2007-06-03
DE69937077T2 (de) 2008-05-29
AU769108B2 (en) 2004-01-15
KR100595806B1 (ko) 2006-07-03
ATE307130T1 (de) 2005-11-15
US6313137B1 (en) 2001-11-06
DE69928792T2 (de) 2006-07-20
DE69928792D1 (de) 2006-01-12
HK1033457A1 (en) 2001-08-31
ES2249913T3 (es) 2006-04-01
ATE312101T1 (de) 2005-12-15
CZ20003982A3 (cs) 2001-02-14
JP2002513024A (ja) 2002-05-08
UA67769C2 (uk) 2004-07-15
NO318203B1 (no) 2005-02-14
DK1073657T3 (da) 2006-03-13
TR200003176T2 (tr) 2001-03-21
TR200102612T2 (tr) 2002-06-21
EP1073657A1 (de) 2001-02-07
EP1073657B1 (de) 2005-12-07
PL343797A1 (en) 2001-09-10
CN1174980C (zh) 2004-11-10
DE69937077D1 (de) 2007-10-18
PL195000B1 (pl) 2007-07-31
EP1073656A1 (de) 2001-02-07
NZ507639A (en) 2004-01-30
HUP0102313A3 (en) 2002-10-28
BR9909996B1 (pt) 2010-08-24
SK14922000A3 (sk) 2001-06-11
AR015769A1 (es) 2001-05-16
SA99200064B1 (ar) 2006-10-11
UA66846C2 (uk) 2004-06-15
KR20050121760A (ko) 2005-12-27
PL343801A1 (en) 2001-09-10
DK1073656T3 (da) 2006-01-16
ZA200005797B (en) 2002-01-18
ES2252975T3 (es) 2006-05-16
ID26819A (id) 2001-02-15
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
CZ293977B6 (cs) 2004-09-15
IL139200A0 (en) 2001-11-25
NZ507638A (en) 2003-10-31
EE200000626A (et) 2002-04-15
EP1491543B1 (de) 2007-09-05
ID27530A (id) 2001-04-12
JP2002513025A (ja) 2002-05-08
SK14912000A3 (sk) 2001-06-11
SE9801526D0 (sv) 1998-04-29
DE69937076D1 (de) 2007-10-18
EE04916B1 (et) 2007-10-15
EP1491542A2 (de) 2004-12-29
CA2329921A1 (en) 1999-11-04
WO1999055705A1 (en) 1999-11-04
CZ20003981A3 (cs) 2001-03-14
KR100595805B1 (ko) 2006-07-03
IS5683A (is) 2000-10-25
DE69937076T2 (de) 2008-05-29
EP1073656B1 (de) 2005-10-19
EE04676B1 (et) 2006-08-15
HK1071139A1 (en) 2005-07-08
JP3692034B2 (ja) 2005-09-07
JP3883383B2 (ja) 2007-02-21
DE69927803D1 (de) 2006-03-02
BR9909995A (pt) 2000-12-26
HK1036984A1 (en) 2002-01-25
KR20010043134A (ko) 2001-05-25
EP1491542A3 (de) 2005-01-05
CA2329922A1 (en) 1999-11-04
MY121379A (en) 2006-01-28
BR9909996A (pt) 2000-12-26
TW490466B (en) 2002-06-11
CN1306533A (zh) 2001-08-01
WO1999055706A9 (en) 2000-03-16
AU4300799A (en) 1999-11-16
AR015768A1 (es) 2001-05-16
CA2329922C (en) 2006-04-11
IL139200A (en) 2010-04-29
KR100650472B1 (ko) 2006-11-28
CN1165535C (zh) 2004-09-08
TR200102728T2 (tr) 2002-06-21
NO317262B1 (no) 2004-09-27
HUP0102313A2 (hu) 2001-12-28

Similar Documents

Publication Publication Date Title
ATE372339T1 (de) Zwischenprodukte für die herstellung von imidazo- pyridin-derivate
DE60034342D1 (de) Verfahren für die herstellung von lufthaltigen gefrorenen produkten
ATE233236T1 (de) Zwischenprodukte für die herstellung von oximäthern
ATE418547T1 (de) Zwischenprodukte zur herstellung von anti- thrombotischen 4h-cyclopenta-1,3-dioxol-derivaten
DE50110695D1 (de) Anlage für die Herstellung von Druckprodukten
DE60021328D1 (de) Herstellungsverfahren für die Herstellung von Aluminat-Phosphor
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
DE69911617D1 (de) Stereolithographische zusammensetzungen für die herstellung polyäthylenähnlicher gegenstände
ATE434598T1 (de) Zwischenprodukte für die herstellung von dioxan-2-alkylcarbamaten
DE69709686D1 (de) Trommel für die herstellung absorbierender artikel
IT1298535B1 (it) Procedimento per la produzione di gamma-butirrolattone
ID26478A (id) Penggambaran kelima macam langkah produksi
IT1298096B1 (it) Procedimento per la produzione di gamma-butirrolattone
ATE270671T1 (de) Zwischenprodukte für die herstellung von naphthyridin-3-carbonsäure-derivaten
IT1268941B1 (it) Macchina per la produzione di croissants
ATE295175T1 (de) Verwendung von unverseifbaren pflanzlichen ölen für die herstellung pharmazeutischer präparate
ATE213494T1 (de) Verfahren und zwischenprodukte, die für die herstellung von antifolaten verwendbar sind
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
DE69802227D1 (de) Aminomethyl-Pyrrolidin-Harnstoff-Zusammensetzungen für die Herstellung von Polyurethanen
TR199500800A2 (tr) Sekil verilmis esyalarin üretilmesi.
ATE485271T1 (de) Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung
HUP0202530A3 (en) Method for the production of phosphonomethylglycin
DE60134845D1 (de) Neuer prozess für die herstellung von polyacetylenderivaten
DE60224968D1 (de) Prozess für die Herstellung von 5-Arylpentanolen
NO983352D0 (no) FramgangsmÕte for produksjon av sulfiderte katalysatorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties